Metraipolis › archive › dc_f7060dbb3441
177Lu-labelled peptide receptor radionuclide therapy in patients with neuroendocrine tumors: a systematic review and meta-analysis — Europe PMC PMID:41798196
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41798196
- DOI
- 10.3389/fendo.2026.1758639
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T13:02:46.285Z
- SHA-256 of the archived text
dd8edb734d6461b7705a075e3492f8ef840119cb59cb5d05d63d4c42449ea5fe- Stable URL of this page
https://metraipolis.com/documento/dc_f7060dbb3441
How to cite
177Lu-labelled peptide receptor radionuclide therapy in patients with neuroendocrine tumors: a systematic review and meta-analysis — Europe PMC PMID:41798196 — Europe PMC (en), https://europepmc.org/article/MED/41798196 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f7060dbb3441 (Metraipolis archive dc_f7060dbb3441, sha256 dd8edb734d6461b7705a075e3492f8ef840119cb59cb5d05d63d4c42449ea5fe)
BibTeX
@misc{dcf7060dbb3441,
title = {177Lu-labelled peptide receptor radionuclide therapy in patients with neuroendocrine tumors: a systematic review and meta-analysis — Europe PMC PMID:41798196},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41798196},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f7060dbb3441; sha256 dd8edb734d6461b7705a075e3492f8ef840119cb59cb5d05d63d4c42449ea5fe},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41798196. Agents can read the archived copy with the MCP tool read_document.